Boule Diagnostics develops and manufactures diagnostic instruments and consumables for healthcare providers worldwide. The company’s primary focus is in small to medium-sized hospitals, clinics, and laboratories in both human and veterinary diagnostics. Boule has a strong heritage when it comes to hematology diagnostics. Our blood tests help provide one of the first and most important indicators of a disease state and Boule systems play an increasingly role in helping build the infrastructure of healthcare for small and medium size patient care environments in both human and veterinary diagnostic markets. Boule operates via subsidiaries in Sweden, the USA, Mexico and Russia. The company products are sold globally primarily through more than 200 distributors and partners in more than 100 countries, supported by Boule’s own local sales and support personnel. The Boule shares are listed on Nasdaq Stockholm since 2011
